ClearRead Xray Pneumothorax

by Riverain Technologies  · Based in United States → — See Clearly. Decide Confidently.™
Critical Care Emergency Medicine Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

ClearRead Xray Pneumothorax: AI-Driven Detection for Chest X-rays

ClearRead Xray Pneumothorax is an AI-powered medical imaging software developed by Riverain Technologies. It is designed to enhance the interpretation of adult upright and portable chest X-rays by providing a triage notification for suspected pneumothorax of 5mm or larger. This tool aims to improve the efficiency and accuracy of radiologists in detecting this life-threatening emergency. Part of the broader ClearRead Xray suite, it leverages unique suppression technology to provide an unimpaired view of the chest, revealing actionable data for cardiothoracic diseases. The solution integrates seamlessly into existing PACS/workstation workflows without requiring additional radiation dose or changes to current imaging protocols.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Triage notification for suspected pneumothorax (5mm or larger)
  • 92% Sensitivity, 95% Specificity for pneumothorax detection
  • Works on all adult upright and portable chest X-ray devices
  • Integrates into existing PACS/workstation workflows via DICOM protocol
  • AI-driven analysis of digital frontal chest radiographs
  • No additional radiation dose or changes to existing imaging protocols
  • Part of the broader ClearRead Xray suite (includes bone suppression, nodule detection, enhancement)

Use Cases

  • Prioritizing chest X-rays for radiologist review
  • Early detection of pneumothorax in emergency settings
  • Improving radiologist efficiency and accuracy in chest X-ray interpretation
  • Supporting diagnosis of cardiothoracic diseases

Details

Category Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentEnterprise-wide deployment on any acquisition device and any PACS; available direct and on major AI platforms & PACS marketplaces; can be installed on stand-alone server, virtual machine, or in the cloud.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

ClearRead Xray Pneumothorax received FDA 510(k) clearance (K213566) on March 10, 2022. It is cleared as a computer-assisted triaging tool to prioritize chest X-rays based on the suspected presence of a pneumothorax 5mm or larger.
Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ClearRead Xray Pneumothorax

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Riverain Technologies
Riverain Technologies Advances Its Mission to Eliminate Delayed Cardiothoracic Disease Diagnoses
Riverain Technologies announced significant milestones in July 2023, including the FDA clearance and MDR approval of its new application, ClearRead Xray Pneumothorax, a computer-assisted tool designed to alert readers to the suspected presence of pneumothorax.
2023-07
Riverain Technologies
Riverain Technologies Brings ClearRead AI-Powered Lung Cancer Detection to Hospitals and VA Medical Centers
Riverain Technologies reported 286% growth and 30 new customers in 2023, with the full commercial release of ClearRead Xray Pneumothorax.
2024-02
FDA
ClearRead Xray Pneumothorax - 510(k) Premarket Notification
This FDA 510(k) summary details the ClearRead Xray Pneumothorax, an AI-powered triage workflow tool cleared on March 10, 2022, designed to prioritize chest X-rays based on the suspected presence of a pneumothorax 5mm or larger.
2022-03
JAMA Network Open (via PMC)
Evaluation of an Artificial Intelligence Model for Detection of Pneumothorax and Tension Pneumothorax in Chest Radiographs
A December 2022 study evaluated an AI model for pneumothorax detection, referencing the ClearRead Xray Pneumothorax FDA approval.
2022-12
medRxiv
Evaluation of an artificial intelligence model for detection of pneumothorax and tension pneumothorax on chest radiograph
This preprint from July 2022 discusses the assessment of an AI model for detecting pneumothorax and tension pneumothorax on chest X-rays, citing the ClearRead Xray Pneumothorax FDA approval.
2022-07
RadAI Slice
Riverain Technologies | Radiology AI Companies - X-ray Interpreter
RadAI Slice lists ClearRead Xray Pneumothorax, released on March 10, 2022, as an AI-powered software tool cleared by the FDA to analyze adult chest X-rays for pneumothorax larger than 5mm and triage urgent cases.
2022-03
TeraRecon
AI Partner Showcase | TeraRecon
TeraRecon's AI Partner Showcase includes Riverain ClearRead Xray Pneumothorax, highlighting Riverain Technologies' dedication to thoracic imaging and software tools for lung disease detection.
unknown
Innolitics
Command Line as a Medical Device (CLaMD)
Innolitics mentions ClearRead Xray Pneumothorax as an example of a Command Line as a Medical Device (CLaMD) in a May 2025 article, noting its passive operation in parallel to standard workflow and DICOM-based result delivery.
2025-05

Videos

Product demos, reviews, and walkthroughs for ClearRead Xray Pneumothorax.

View all on YouTube

Frequently Asked Questions

ClearRead Xray Pneumothorax functions as a computer-assisted triage tool, providing a notification for suspected pneumothorax cases 5mm or larger on adult upright and portable chest X-rays. It integrates into existing PACS/workstation systems to prioritize studies for radiologist review, aiming to improve workflow efficiency.
ClearRead Xray Pneumothorax has received FDA clearance and is approved under Medical Device Reporting (MDR), classifying it as a Class II medical device. This ensures it meets established safety and effectiveness standards for use in clinical settings.
Yes, several AI solutions exist for pneumothorax detection, including those from other vendors like GE Healthcare's Critical Care Suite. ClearRead Xray Pneumothorax differentiates itself by providing a triage notification for pneumothorax 5mm or larger, and it is part of a broader suite of AI tools that offer bone suppression and nodule detection to enhance overall chest X-ray interpretation.
The pricing model for ClearRead Xray Pneumothorax typically involves either a one-time license fee or a subscription-based model. The cost is generally structured based on the number of analyses performed by the software.
ClearRead Xray Pneumothorax is an adjunctive tool intended for notification and triage, not for definitive diagnosis, and requires both lungs to be in the field of view on adult, digital frontal chest radiographs. While AI tools can improve detection, studies suggest they may produce more false positives than human radiologists, and performance can decrease with multiple findings or very subtle targets.

Compare ClearRead Xray Pneumothorax

VS
CINA-VCF vs ClearRead Xray Pneumothorax
Radiology & Imaging AI Adjacent · 70/100
CINA-VCF and ClearRead Xray Pneumothorax are adjacent healthcare-AI tools, both designed for triage and notification in radiology. CINA-VCF focuses on detecting vertebral compression fractures on CT scans, primarily…
VS
CINA-CSpine vs ClearRead Xray Pneumothorax
Radiology & Imaging AI Adjacent · 65/100
These tools are adjacent competitors, both serving as AI-powered triage solutions for emergency radiology to enhance diagnostic accuracy and efficiency. However, CINA-CSpine focuses on detecting acute cervical spine…
VS
QuickRad vs ClearRead Xray Pneumothorax
Radiology & Imaging AI Adjacent · 60/100
QuickRad is an end-to-end AI-integrated PACS and RIS system designed to manage and optimize the entire radiology workflow, including image handling, reporting, and analytics. In contrast, ClearRead Xray…
VS
a2z-Unified-Triage vs ClearRead Xray Pneumothorax
Radiology & Imaging AI Adjacent · 68/100
While both tools offer AI-driven triage in emergency radiology, they address distinct clinical needs and imaging modalities. Tool A, a2z-Unified-Triage, focuses on simultaneously flagging seven urgent findings on…

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Starts from $0/month (free plan) to $2,999/month (lead plan) for octa core.
Smart Reporting
Smart Reporting
Clinical Decision Support & Reference
A German health tech startup uses artificial intelligence to cut time spent on medical reports and improve patient care. Founded by a radiologist, Smart Reporting aims to standardize reporting and minimize documentation time, addressing the looming threat of physician shortage in Europe.
RetiVue EntireEye Imaging
RetiVue, LLC
Ophthalmology AI
RetiVue manufactures ultrawidefield retinal cameras with automatic image capture, aiming to aid in the early documentation of eye disease and prevent blindness. Their EntireEye Imaging System offers both desktop and portable options, providing true color, high-detail images with a wide field of view for patients from infancy to adulthood.
Paid
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
Augmentiqs Augmented Reality Microscope (ARM)
Augmentiqs Medical Ltd.
Clinical Decision Support & Reference
Augmentiqs integrates augmented reality into existing microscopes, providing real-time access to digital pathology software, AI algorithms, and telepathology capabilities directly within the microscope's field of view.
AI Optics Sentinel Camera
AI Optics
Ophthalmology AI
AI Optics' Sentinel Camera is an FDA 510(k)-cleared handheld retinal imaging system designed to capture high-quality images for retinal disease screening, with future plans for integrated AI-based screening software for diabetic retinopathy, glaucoma, and macular degeneration.

See all Radiology & Imaging AI tools →

More from Riverain Technologies

CLEARREAD +CONFIRM
RIVERAIN TECHNOLOGIES
Radiology & Imaging AI
CLEARREAD +CONFIRM is an AI tool by Riverain Technologies that enhances chest X-ray images to improve the visibility and confirmation of lines and tubes, reducing reading time by approximately 19% for radiologists.
Not publicly available
ClearRead CT
RIVERAIN TECHNOLOGIES
Cardiology AI
ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
Contact for pricing
ClearRead CT CAC
Riverain Technologies
Cardiology AI
ClearRead CT CAC by Riverain Technologies is an AI-powered software that enables opportunistic screening for coronary artery calcification (CAC) by accurately detecting, quantifying, and reporting Agatston scores from routine, ungated, non-contrast chest CT scans.
Contact vendor for pricing details
DELTAVIEW MODEL
Riverain Technologies
Oncology AI
DELTAVIEW MODEL, by Riverain Technologies (formerly Riverain Medical Group), is an AI-driven medical imaging software for temporal comparison of chest X-rays, designed to detect subtle changes like early-stage lung cancer nodules through bone suppression and image subtraction technology.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.